Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 9.84
+0.06 (0.61%)
Mar 9, 2026, 5:29 PM CET
Vicore Pharma Holding AB Revenue
In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M SEK, down -96.51%. Vicore Pharma Holding AB had revenue of 419.00K in the quarter ending December 31, 2025, a decrease of -91.79%.
Revenue
3.82M
Revenue Growth
-96.51%
P/S Ratio
725.76
Revenue / Employee
106.03K
Employees
36
Market Cap
2.77B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Flerie AB | 2.80M |
| Hansa Biopharma AB | 222.27M |
| Egetis Therapeutics AB | 62.40M |
| Diamyd Medical AB | 349.00K |
| Saniona AB | 434.40M |
| BioInvent International AB | 226.50M |
| Genovis AB (publ.) | 129.65M |
| Cantargia AB | 316.70M |
Vicore Pharma Holding AB News
- 5 days ago - Vicore Pharma Holding AB at TD Cowen Healthcare Conference Transcript - GuruFocus